- Home
- TLSI vs TTEC Comparison
TLSI vs TTEC Comparison
Compare TLSI & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- TTEC
- Stock Information
- Founded
- TLSI 2010
- TTEC 1982
- Country
- TLSI United States
- TTEC United States
- Employees
- TLSI N/A
- TTEC N/A
- Industry
- TLSI Medical Specialities
- TTEC Retail: Computer Software & Peripheral Equipment
- Sector
- TLSI Health Care
- TTEC Technology
- Exchange
- TLSI Nasdaq
- TTEC Nasdaq
- Market Cap
- TLSI 160.4M
- TTEC 178.1M
- IPO Year
- TLSI N/A
- TTEC 1996
- Fundamental
- Price
- TLSI $5.02
- TTEC $5.30
- Analyst Decision
- TLSI Strong Buy
- TTEC Buy
- Analyst Count
- TLSI 6
- TTEC 4
- Target Price
- TLSI $11.75
- TTEC $10.83
- AVG Volume (30 Days)
- TLSI 34.6K
- TTEC 328.2K
- Earning Date
- TLSI 05-23-2025
- TTEC 05-08-2025
- Dividend Yield
- TLSI N/A
- TTEC N/A
- EPS Growth
- TLSI N/A
- TTEC N/A
- EPS
- TLSI N/A
- TTEC N/A
- Revenue
- TLSI $29,431,000.00
- TTEC $2,165,177,000.00
- Revenue This Year
- TLSI $55.13
- TTEC N/A
- Revenue Next Year
- TLSI $50.71
- TTEC N/A
- P/E Ratio
- TLSI N/A
- TTEC N/A
- Revenue Growth
- TLSI 58.99
- TTEC N/A
- 52 Week Low
- TLSI $3.50
- TTEC $3.11
- 52 Week High
- TLSI $10.24
- TTEC $8.45
- Technical
- Relative Strength Index (RSI)
- TLSI 34.87
- TTEC 73.36
- Support Level
- TLSI $4.66
- TTEC $3.72
- Resistance Level
- TLSI $5.40
- TTEC $4.07
- Average True Range (ATR)
- TLSI 0.37
- TTEC 0.30
- MACD
- TLSI -0.06
- TTEC 0.07
- Stochastic Oscillator
- TLSI 29.51
- TTEC 95.10
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About TTEC TTEC Holdings Inc.
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and most of the sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.